CLSI I/LA28-A2 (R2018) PDF

CLSI I/LA28-A2 (R2018) PDF

Name:
CLSI I/LA28-A2 (R2018) PDF

Published Date:
01/01/2011

Status:
Active

Description:

Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline-Second Edition, ILA28A2E

Publisher:
Clinical and Laboratory Standards Institute

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$54
Need Help?
Immunohistochemistry is an analytical technique that applies an antibody reagent to detect and visualize an antigen in cytological and surgical pathology microscopy specimens in the context of histomorphology and cytomorphology. The clinical-pathological interpretation of the presence and patterns of the antibody-antigen reactions is performed in a manner similar to other molecular pathology assays. Immunohistochemistry is used in diagnostic pathology for diagnosis, determination of prognosis, and predictive assays for response to therapy. Accurate and reproducible results require quality assurance of the total test system including the design control of the reagents and the preexamination (preanalytical), examination (analytical), and postexamination (postanalytical) interpretation steps (processes) of the assay to ensure its clinical applicability. This guideline focuses on validation of immunohistochemistry assays on formalin-fixed, paraffin-embedded pathology material. The audience for this guideline includes the assay developer, the reagent supplier, laboratory histotechnologist who performs the assay, and the laboratory director/pathologist who implements and interprets the assay.
File Size : 1 file , 2.4 MB
ISBN(s) : 1562387456
Note : This product is unavailable in Russia, Belarus
Number of Pages : 156
Published : 01/01/2011

History

CLSI I/LA28-A2 (R2018)
Published Date: 01/01/2011
Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline-Second Edition, ILA28A2E
$54
CLSI MM04-A
Published Date: 12/01/1999
Quality Assurance for Immunocytochemistry; Approved Guideline, MM04A

Related products

CLSI NBS06-A
Published Date: 04/01/2013
Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE
$54
CLSI NBS05
Published Date: 12/01/2019
Newborn Screening for Cystic Fibrosis, 2nd Edition, NBS05Ed2E
$54
CLSI QMS12
Published Date: 03/29/2019
Developing and Using Quality Indicators for Laboratory Improvement, 2nd Edition, QMS12Ed2E
$54

Best-Selling Products

RVIA 12V
Published Date: 01/01/2002
STANDARD FOR LOW VOLT SYSTEMS IN CONVERSION & RECREATIONAL VEHICLES
RVIA 12V
Published Date: 01/01/2008
STANDARD FOR LOW VOLT SYSTEMS IN CONVERSION & RECREATIONAL VEHICLES
RVIA 12V
Published Date: 01/01/2018
STANDARD FOR LOW VOLT SYSTEMS IN CONVERSION & RECREATIONAL VEHICLES
RVIA 12V
Published Date: 01/01/2005
STANDARD FOR LOW VOLT SYSTEMS IN CONVERSION & RECREATIONAL VEHICLES
RVIA 12V
Published Date: 01/01/2020
STANDARD FOR LOW VOLT SYSTEMS IN CONVERSION & RECREATIONAL VEHICLES
RVIA 12V
Published Date: 01/01/2011
STANDARD FOR LOW VOLT SYSTEMS IN CONVERSION & RECREATIONAL VEHICLES